The goal of this activity is to inform clinicians about the current indications and guideline recommendations for immunotherapy in gastric/gastroesophageal junction cancers, and discuss ongoing clinical trials.
This activity is intended for oncologists, gastroenterologists, and pathologists.
- Have increased knowledge regarding the
- Immunotherapy-based treatment in the management of gastric/GEJ cancers
- Have greater competence related to
- Identifying patients for immunotherapy-based treatment in the appropriate clinical setting reflective of biomarkers and previous treatments
Approximate Time to Complete: 30 minutes
Credit Available: April 5, 2021 - April 5, 2022
Developed through a partnership between SITC and Medscape.
Additional Resources for Clinicans from SITC: